TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25889758

Group type: EXPERIMENTAL
Intervention: Motivationally-enhanced learning modules
Number of subjects: 127

Group type: COMPARATOR
Intervention: Standard learning modules
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Both formats (standard and enhanced)
Number of subjects: 127
Study: 23485788

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO) therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intravesical dimethyl sulfoxide (DMSO)
Number of subjects: 20
Study: 20298505

Group type: EXPERIMENTAL
Intervention: Diabetes present
Number of subjects: 315
Study: 19583647

Group type: EXPERIMENTAL
Intervention: Music listening during bed rest (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bed rest only (n = 20)
Number of subjects: 40
Study: 17019406

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (healthy female volunteers without a family history of depression)
Number of subjects: 0
Study: 15202814

Group type: EXPERIMENTAL
Intervention: Extended daily dialysis (EDD)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Continuous hemodialysis (CHD)
Number of subjects: 54
Study: 11840808

Group type: EXPERIMENTAL
Intervention: 12.5 mg capoten at 10.00
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 12.5 mg capoten at 13.00
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 12.5 mg capoten at other hours (7.00, 16.00, 19.00, 22.00)
Number of subjects: 70
Study: 9949668

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg daily, increasing to 2-3 tablets based on metabolic control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Insulin (24 units subcutaneously, adjusted based on metabolic response)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Controlled diet (in non-diabetic obese patients)
Number of subjects: 60
Study: 7815986

Group type: EXPERIMENTAL
Intervention: E. coli preparation (Mutaflor)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 31761120

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) for dust mite
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) for latex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) for venom hypersensitivity
Number of subjects: 0
Study: 31351679

Group type: EXPERIMENTAL
Intervention: Sufentanil during induction of remifentanil-based total intravenous anesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (remifentanil-based total intravenous anesthesia without sufentanil)
Number of subjects: 40
Study: 27677168

Group type: EXPERIMENTAL
Intervention: Depression score increase
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Anxiety score increase
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Likely anxiety category
Number of subjects: 228
Study: 25925891

Group type: EXPERIMENTAL
Intervention: Concurrent administration of abiraterone acetate plus prednisone (AA + P)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Sequential administration of abiraterone acetate plus prednisone (AA + P)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Sipuleucel-T
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Combination of sipuleucel-T with AA + P
Number of subjects: 69
Study: 23557454

Group type: EXPERIMENTAL
Intervention: Empowering program (twice a week for 60 minutes over 6 weeks)
Number of subjects: 46
Study: 21822750

Group type: EXPERIMENTAL
Intervention: 1‐year internet‐based weight loss intervention
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: 1‐year internet‐based weight loss intervention (high tertile participation)
Number of subjects: 441
Study: 19689759

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting
Number of subjects: 3640

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 3640

Group type: COMPARATOR
Intervention: State-of-the-art conservative treatment
Number of subjects: 3640
Study: 16963365

Group type: EXPERIMENTAL
Intervention: Manual hyperinflation (MHI)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Ventilator hyperinflation (VHI)
Number of subjects: 14
Study: 15589436

Group type: EXPERIMENTAL
Intervention: Foot orthotics
Number of subjects: 16
Study: 11203746

Group type: EXPERIMENTAL
Intervention: Standardized biasing statement
Number of subjects: 40

Group type: COMPARATOR
Intervention: No biasing statement (Control)
Number of subjects: 40
Study: 9484514

Group type: EXPERIMENTAL
Intervention: Triflusal (Disgren), 900 mg/day (300 mg 3 times a day)
Number of subjects: 217

Group type: COMPARATOR
Intervention: AAS (Sedergine) 330 mg/day (once a day)
Number of subjects: 217
Study: 8147246

Group type: EXPERIMENTAL
Intervention: 150 micrograms desogestrel
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 75 micrograms gestodene
Number of subjects: 61
Study: 3530368

Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 40

Group type: COMPARATOR
Intervention: Inactive TENS (Control)
Number of subjects: 40
Study: 31821716

Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (G/P) treatment for chronic HCV infection
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (G/P) treatment
Number of subjects: 101
Study: 29227175

Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis HN019 (1 × 109 CFU/day)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis HN019 (1 × 1010 CFU/day)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Bifidobacterium animalis subsp. lactis HN019 (combined high and low dose)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Bifidobacterium animalis subsp. lactis HN019 (high-dose)
Number of subjects: 228
Study: 26880227

Group type: EXPERIMENTAL
Intervention: Prucalopride (2 mg/day)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 24183868

Group type: EXPERIMENTAL
Intervention: Postoperative concurrent radiochemotherapy (POCRT) with paclitaxel (175 mg/m²) and cisplatin (60 mg/m²) for four cycles, plus radiotherapy (50.4 Gy/28 fractions) concurrently with the first 2 cycles of chemotherapy.
Number of subjects: 135

Group type: COMPARATOR
Intervention: Postoperative chemotherapy (POCT) with paclitaxel (175 mg/m²) and cisplatin (60 mg/m²) for four cycles.
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Postoperative concurrent radiochemotherapy (POCRT) for patients with ≥2 pN2 lymph nodes.
Number of subjects: 135
Study: 21853265

Group type: EXPERIMENTAL
Intervention: Synbiotic dietary supplement (Lactobacillus acidophilus NCFM and lactitol, 10 g lactitol and 2×10^10 cells of probiotic bacteria, taken twice a day for 2 weeks)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 51
Study: 20501489

Group type: EXPERIMENTAL
Intervention: Intermittent claudication
Number of subjects: 5011
Study: 18377658

Group type: EXPERIMENTAL
Intervention: Thalidomide with zoledronic acid
Number of subjects: 24

Group type: COMPARATOR
Intervention: Zoledronic acid alone
Number of subjects: 24
Study: 15955124

Group type: EXPERIMENTAL
Intervention: Metformin (1 g bd)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg bd)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 11823661

Group type: EXPERIMENTAL
Intervention: CADASIL individuals
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Nondisabled CADASIL individuals (Rankin score=0, n=9)
Number of subjects: 17
Study: 10429603

Group type: EXPERIMENTAL
Intervention: Tourniquet released for hemostasis before wound closure
Number of subjects: 81

Group type: COMPARATOR
Intervention: Tourniquet not released until wound closure and compressive dressing applied
Number of subjects: 81
Study: 7771999

Group type: EXPERIMENTAL
Intervention: Vigorous exercise (at least 30 minutes, at least 3 times weekly)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (healthy pregnant women who did not do regular vigorous exercise)
Number of subjects: 0
Study: 2268437

Group type: EXPERIMENTAL
Intervention: Operative blood temperature of 20 degrees C
Number of subjects: 20

Group type: COMPARATOR
Intervention: Operative blood temperature of 28 degrees C
Number of subjects: 20
Study: 476908

Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 95

Group type: COMPARATOR
Intervention: Cow's milk-based formula
Number of subjects: 95

Group type: COMPARATOR
Intervention: Proprietary infant milk formula
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Solid foods introduced at 3.5 months
Number of subjects: 95
Study: 30762770

Group type: EXPERIMENTAL
Intervention: Traditional acupuncture and placebo pills
Number of subjects: 208

Group type: COMPARATOR
Intervention: Sham-acupoints acupuncture and antidepressant (fluoxetine hydrochloride tablets)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Traditional acupuncture
Number of subjects: 208
Study: 28152332

Group type: EXPERIMENTAL
Intervention: MenACWY-TT (Pfizer)
Number of subjects: 322

Group type: COMPARATOR
Intervention: MenPS (GSK Vaccines)
Number of subjects: 322
Study: 25641237

Group type: EXPERIMENTAL
Intervention: Higher maternal education
Number of subjects: 1347

Group type: EXPERIMENTAL
Intervention: Higher paternal education
Number of subjects: 1347

Group type: EXPERIMENTAL
Intervention: Caregiver employment
Number of subjects: 1347

Group type: EXPERIMENTAL
Intervention: Presence of all three social advantages (higher maternal education, higher paternal education, caregiver employment)
Number of subjects: 1347
Study: 24699550

Group type: EXPERIMENTAL
Intervention: Intracoronary verapamil
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 46
Study: 23008300

Group type: EXPERIMENTAL
Intervention: PEG‐IFN‐α‐2b
Number of subjects: 1256

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 1256
Study: 18977787

Group type: EXPERIMENTAL
Intervention: Paediatric Analgesia Wheel
Number of subjects: 52

Group type: COMPARATOR
Intervention: BNF for children (BNFC)
Number of subjects: 52
Study: 17537117

Group type: EXPERIMENTAL
Intervention: BioSeed-S treatment with compression therapy (3‐6 x 10(6)/mL autologous keratinocytes with fibrin sealant)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Standard care with compression therapy
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: BioSeed-S treatment with compression therapy
Number of subjects: 225
Study: 15283821

Group type: EXPERIMENTAL
Intervention: 0.15 mg x kg(‐1) rocuronium (group I)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 0.3 mg x kg(‐1) rocuronium (group II)
Number of subjects: 44
Study: 11207468

Group type: EXPERIMENTAL
Intervention: Propofol (group R/P)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Desflurane (group R/D)
Number of subjects: 50
Study: 9471087

Group type: EXPERIMENTAL
Intervention: Safer Choices program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 8517168

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 336

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 336
Study: 3429698

Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg each morning for five doses)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg tid for 12 doses)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Itazigrel (25 mg each morning for five doses)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Itazigrel (50 mg tid for 12 doses)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 29345426

Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (FCM) 1000 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 50
Study: 26729330

Group type: EXPERIMENTAL
Intervention: Telemedicine meditation intervention (2 hours/week of online meditation in a group setting led by a trainer, plus 1 hour/week of individual exercises)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Psycho‐education online program (control condition)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Telemedicine meditation intervention
Number of subjects: 120
Study: 23389902

Group type: EXPERIMENTAL
Intervention: TRAM flap breast reconstruction in underweight patients
Number of subjects: 335

Group type: COMPARATOR
Intervention: TRAM flap breast reconstruction in normal weight patients
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: TRAM flap breast reconstruction in both groups
Number of subjects: 335
Study: 23209728

Group type: EXPERIMENTAL
Intervention: 24-week clevudine therapy
Number of subjects: 50
Study: 19907913

Group type: EXPERIMENTAL
Intervention: TVT
Number of subjects: 300

Group type: COMPARATOR
Intervention: TVT-O
Number of subjects: 300
Study: 17347074

Group type: EXPERIMENTAL
Intervention: Metoprolol (5 mg administered via venous cannula)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Diltiazem (25 mg administered via venous cannula)
Number of subjects: 64
Study: 15448121

Group type: EXPERIMENTAL
Intervention: Sustained hypoxia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclic hypoxia
Number of subjects: 0
Study: 11871368

Group type: EXPERIMENTAL
Intervention: Red palm oil (5 ml)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Red palm oil (10 ml)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ground nut oil fortified with 400 retinol equivalent retinol palmitate
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ground nut oil fortified with 800 retinol equivalent retinol palmitate
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ground nut oil (5 ml)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ground nut oil (10 ml)
Number of subjects: 6
Study: 9884318

Group type: EXPERIMENTAL
Intervention: 8 mg ondansetron
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1 mg granisetron
Number of subjects: 20
Study: 8772213

Group type: EXPERIMENTAL
Intervention: Impedance plethysmography (IPG)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Compression ultrasonography (CUS)
Number of subjects: 495
Study: 2252183

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 60
Study: 7408393

Group type: EXPERIMENTAL
Intervention: 0.5 mg digoxin intravenously
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1.0 mg digoxin intravenously
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1.5 mg digoxin intravenously
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.25 mg digoxin intravenously every 24 hr for 10 consecutive days
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Multiple-dose digoxin therapy
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Single-dose kinetics
Number of subjects: 9
Study: 31843695

Group type: EXPERIMENTAL
Intervention: Bariatric surgery group
Number of subjects: 669

Group type: COMPARATOR
Intervention: Control group (BMI >40 kg/m2 without bariatric surgery)
Number of subjects: 669
Study: 30702059

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (765 mg)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Standard oral naltrexone (2 x 50 mg on Monday and Wednesday; 3 x 50 mg on Friday for 4 weeks, then patient-administered for 8 weeks)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 28152319

Group type: EXPERIMENTAL
Intervention: Oral antioxidant supplementation (Squalene 100 mg, Vitamin C 30 mg, Coenzyme Q10 10 mg, Zinc 5 mg, Beta Carotene 3.6 mg, Bioflavonoids 30 mg, Selenium 55 mcg) administered daily for 2 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no antioxidant supplementation)
Number of subjects: 20
Study: 25749317

Group type: EXPERIMENTAL
Intervention: Vitamin A intake in hypertensive subpopulation (1732.77±962.27 µg)
Number of subjects: 1514

Group type: EXPERIMENTAL
Intervention: Vitamin D intake in hypertensive subpopulation (8.13±9.71 µg)
Number of subjects: 1514

Group type: EXPERIMENTAL
Intervention: Vitamin E intake in hypertensive subpopulation (18.79±7.84 mg)
Number of subjects: 1514
Study: 24229754

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 50 mg/d
Number of subjects: 434

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 434
Study: 21557117

Group type: EXPERIMENTAL
Intervention: Computer course
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 259

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 259
Study: 19407333

Group type: EXPERIMENTAL
Intervention: 6-week community-based, peer-led diabetes self-management program (DSMP)
Number of subjects: 345

Group type: COMPARATOR
Intervention: usual-care control group
Number of subjects: 345
Study: 17803388

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) at 10 J/cm(2) or 15 J/cm(2)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo treatment at 0.1 J/cm(2)
Number of subjects: 80
Study: 14748768

Group type: EXPERIMENTAL
Intervention: OCSP classification (LACS, PACS, TACS, POCS)
Number of subjects: 759

Group type: EXPERIMENTAL
Intervention: TACS
Number of subjects: 759

Group type: EXPERIMENTAL
Intervention: PACS
Number of subjects: 759

Group type: EXPERIMENTAL
Intervention: LACS
Number of subjects: 759

Group type: EXPERIMENTAL
Intervention: POCS
Number of subjects: 759
Study: 11515850

Group type: EXPERIMENTAL
Intervention: Prolonged-release granules (2 packets twice daily)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Prolonged-release granules (1 packet four times daily)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Prolonged-release tablets (2 tablets four times daily)
Number of subjects: 227
Study: 9935253

Group type: COMPARATOR
Intervention: Treatment A: two 100-mg trovafloxacin tablets given orally with 240 mL water
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Treatment B: two crushed 100-mg trovafloxacin tablets suspended in water and administered through a nasogastric tube into the stomach
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Treatment C: two crushed 100-mg trovafloxacin tablets suspended in water and administered through a nasogastric tube into the duodenum
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Treatment D: two crushed 100-mg trovafloxacin tablets suspended in water and given through a nasogastric tube into the stomach with enteral feeding solution
Number of subjects: 24
Study: 8118758

Group type: EXPERIMENTAL
Intervention: Sustained-release monofluorophosphate (MFP-SR) 76 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Plain monofluorophosphate (MFP) 76 mg
Number of subjects: 6
Study: 2865889

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31415193

Group type: EXPERIMENTAL
Intervention: Linking Information and Families Together intervention (weekly text messages, telephone calls, or e‐mails about missed assignments, grades, and behavior)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 318
Study: 29198854

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane (TAP) blocks
Number of subjects: 67

Group type: COMPARATOR
Intervention: Thoracic epidural anesthesia (TEA)
Number of subjects: 67
Study: 27634828

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Zotarolimus-eluting stent (ZES)
Number of subjects: 304
Study: 25299792

Group type: EXPERIMENTAL
Intervention: Tactile feedback through electrical stimulation triggered by body sway
Number of subjects: 22
Study: 23149426

Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM) program
Number of subjects: 201
Study: 20549830

Group type: EXPERIMENTAL
Intervention: HLA-Cw 06 positive cohort
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: HLA-Cw 06 negative cohort
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Autoimmunity group
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Nonautoimmunity group
Number of subjects: 284
Study: 17650736

Group type: EXPERIMENTAL
Intervention: Physiotherapy management with integrated components of cognitive‐behavioural origin
Number of subjects: 33

Group type: COMPARATOR
Intervention: Regular primary care physiotherapy
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Patients with high self‐efficacy
Number of subjects: 33
Study: 17237315

Group type: EXPERIMENTAL
Intervention: Isolated isoflavone supplementation (84 mg/d)
Number of subjects: 37
Study: 15492576

Group type: EXPERIMENTAL
Intervention: Epidural analgesia with bupivacaine/fentanyl
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intravenous morphine (patient-controlled analgesia)
Number of subjects: 20
Study: 10928578

Group type: EXPERIMENTAL
Intervention: Gabapentin 1800 mg per day
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Gabapentin 3600 mg per day
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 8756922

Group type: EXPERIMENTAL
Intervention: Doppler ultrasound measurement of hepatic artery resistive index
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Doppler ultrasound measurement of systolic acceleration time
Number of subjects: 5
Study: 1569453

Group type: EXPERIMENTAL
Intervention: High dose intravenous methotrexate (HD; 4 g/m2)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Low dose intravenous methotrexate (LD; 40 mg/m2)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Cranial irradiation (CRT) 1,800 cGy or 2,800 cGy
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Sex (female)
Number of subjects: 51
Study: 3839174

Group type: EXPERIMENTAL
Intervention: dezocine (0.125 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ciramadol (0.6 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: morphine (0.125 mg/kg)
Number of subjects: 30
Study: 31997237

Group type: EXPERIMENTAL
Intervention: Qixiong Zhongzi Decoction (QZD) 150 mL twice a day for 12 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Levocarnitine oral liquid 1 g twice a day for 12 weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Qixiong Zhongzi Decoction (QZD)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Levocarnitine oral liquid
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study: 30898578

Group type: EXPERIMENTAL
Intervention: Resting state EEG
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: MATRICS Consensus Cognitive Battery (MCCB)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Correlation analysis
Number of subjects: 145